Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for peri-extubation sedation after Stanford type B aortic dissection intervention
ChiCTR2300073797Phase 4Recruiting
- Sponsor
- Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in aortic dissection (2 arms), sponsored by Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University. Primary endpoint: Mean arterial pressure at different time points. Started Mar 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
aortic dissection
Beyond the preview
Go deeper on ChiCTR2300073797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073797.